HealthTree

Your Feed

Filter by

See content from

Back to the latest

ASH 2023: Loncastuximab for High-Risk Relapsed/Refractory Follicular Lymphoma

ASH 2023: Loncastuximab for High-Risk Relapsed/Refractory Follicular Lymphoma image

The ABC's of Giving to DLBCL Research

The ABC's of Giving to DLBCL Research image

The ABC's of Giving to Follicular Lymphoma Research

The ABC's of Giving to Follicular Lymphoma Research image

ASH 2023: On the Way to Improved Treatment for Newly Diagnosed Follicular Lymphoma with Acalabrutinib Added to Lenalidomide and Rituximab

ASH 2023: On the Way to Improved Treatment for Newly Diagnosed Follicular Lymphoma with Acalabrutinib Added to Lenalidomide and Rituximab image

$Thumbnail for Loncastuximab for High-Risk Relapsed/Refractory FL | Juan Pablo Alderuccio, MD | ASH 2023$

Playlist: ASH 2023

Loncastuximab for High-Risk Relapsed/Refractory FL | Juan Pablo Alderuccio, MD | ASH 2023

Video details & playlist

Thumbnail for Fighting DLBCL by Attacking the Microenviroment | Leandro Cerchietti, MD | ASH 2023

Playlist: ASH 2023

Fighting DLBCL by Attacking the Microenviroment | Leandro Cerchietti, MD | ASH 2023

Video details & playlist

Thumbnail for Moving Towards Immunotherapy for Newly Diagnosed DLBCL Patients | Paolo Strati, MD | ASH 2023

Playlist: ASH 2023

Moving Towards Immunotherapy for Newly Diagnosed DLBCL Patients | Paolo Strati, MD | ASH 2023

Video details & playlist

My Loved One Has Passed Away. Where Do I Go From Here? image

My Loved One Has Passed Away. Where Do I Go From Here?

02:00PM - 03:00PM EST

Watch Recording

Making The Most of Your Retirement Income

Making The Most of Your Retirement Income image

Making The Most of Your Retirement Income

Making The Most of Your Retirement Income image

Caring for the Lymphoma Caregiver

Caring for the Lymphoma Caregiver image

Caring for the DLBCL Caregiver

Caring for the DLBCL Caregiver image

Promising Results For Treating DLBCL With Odronextamab

Promising Results For Treating DLBCL With Odronextamab image

DLBCL Patient Mental Wellness: Radical Acceptance Technique

DLBCL Patient Mental Wellness: Radical Acceptance Technique image

Chemotherapy Treatment And The Use Of Rituximab In DLBCL

Chemotherapy Treatment And The Use Of Rituximab In DLBCL image

Polivy Is A New Line Of Treatment For DLBCL

Polivy Is A New Line Of Treatment For DLBCL image

HealthTree User • Admin

Follicular Lymphoma Discussion • October 18, 2023

Helpful SCT Packing & Comfort Items List

AI-generated title

Here is a link to helpful/comfort items for stem cell transplant. If you would like a printable PDF version of the document emailed to you, please email me at michelle@healthtree.org https://docs.google.com/document/d/1JMtkmIL6D0Y3LdL3ecBMj3t3cQYi7SWnSBHqU3xGl1A/edit?usp=sharing

Helpful Comfort Items for Transplant

Helpful Comfort Items for Transplant

https://docs.google.com/document/d/1JMtkmIL6D0Y3LdL3ecBMj3t3cQYi7SWnSBHqU3xGl1A/edit?usp=sharing

Preparing for Medicare Advantage Enrollment 2024

Preparing for Medicare Advantage Enrollment 2024 image

MSKCC’s Clinical Trial: Reversing CAR T-cell Exhaustion with Antioxidants

MSKCC’s Clinical Trial: Reversing CAR T-cell Exhaustion with Antioxidants image

What is Chemo Brain?

What is Chemo Brain? image

What is Chemo Brain?

What is Chemo Brain? image

DLBCL Patients - What is CAR T-Cell Therapy?

DLBCL Patients - What is CAR T-Cell Therapy? image

Promising Results Treating Relapsed and Refractory Follicular Lymphoma with Zanubrutinib & Obinutuzumab

Promising Results Treating Relapsed and Refractory Follicular Lymphoma with Zanubrutinib & Obinutuzumab image

The FDA Approves Columvi For Relapsed/Refractory DLBCL

The FDA Approves Columvi For Relapsed/Refractory DLBCL image

More from HealthTree